arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

DAVITA INC.

DVA
$183.77 ▲ +3.10 (+1.72%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
74 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
48
Health
Weak
Bearish
auto_awesome

Analytical Summary

DAVITA INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $12.4B
Dividend Yield
Revenue Growth 6.0%
Op. Margin 14.1%
ROIC -51.4%
FCF / Share $3.25
Trailing P/E 62.7x
Price / Book
FCF Yield 1.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.42B
↑ +6.0%
Net Income Profit after all expenses
$197.53M
↑ +21.2%
Operating Margin Operating profit as % of sales
14.1%
↓ -9.0% 67th
FCF / Share Free cash flow per share
$3.25
↑ +601.2%
Long-Term Debt Long-term obligations
$8.50B
↑ +1.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
60
Returns
7
Financial Health
69
Cash Quality
83

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters